PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.86%
Revenue growth at 50-75% of NXPI's 11.86%. Martin Whitman would worry about competitiveness or product relevance.
7.84%
Gross profit growth under 50% of NXPI's 26.89%. Michael Burry would be concerned about a severe competitive disadvantage.
55.61%
EBIT growth below 50% of NXPI's 183.64%. Michael Burry would suspect deeper competitive or cost structure issues.
50.63%
Operating income growth under 50% of NXPI's 183.64%. Michael Burry would be concerned about deeper cost or sales issues.
68.30%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
65.22%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
72.73%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.26%
Share reduction while NXPI is at 0.12%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.94%
Reduced diluted shares while NXPI is at 0.12%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.26%
Dividend growth of 0.26% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
50.33%
OCF growth under 50% of NXPI's 177.32%. Michael Burry might suspect questionable revenue recognition or rising costs.
52.89%
FCF growth under 50% of NXPI's 268.63%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
157.09%
10Y revenue/share CAGR above 1.5x NXPI's 5.04%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
22.78%
5Y revenue/share CAGR above 1.5x NXPI's 5.04%. David Dodd would look for consistent product or market expansions fueling outperformance.
50.86%
3Y revenue/share CAGR above 1.5x NXPI's 5.04%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
190.70%
10Y OCF/share CAGR 1.25-1.5x NXPI's 166.83%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-5.25%
Negative 5Y OCF/share CAGR while NXPI is at 166.83%. Joel Greenblatt would question the firm’s operational model or cost structure.
34.69%
3Y OCF/share CAGR under 50% of NXPI's 166.83%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
682.46%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-7.84%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
90.65%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
63.47%
Equity/share CAGR of 63.47% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
22.37%
Equity/share CAGR of 22.37% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
34.60%
Equity/share CAGR of 34.60% while NXPI is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
643.71%
Dividend/share CAGR of 643.71% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
113.74%
Dividend/share CAGR of 113.74% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
55.92%
3Y dividend/share CAGR of 55.92% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
10.22%
AR growth well above NXPI's 7.85%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.73%
Inventory shrinking or stable vs. NXPI's 4.04%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-2.44%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.05%
Positive BV/share change while NXPI is negative. John Neff sees a clear edge over a competitor losing equity.
-11.01%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-5.70%
Our R&D shrinks while NXPI invests at 5.41%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.30%
We cut SG&A while NXPI invests at 4.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.